$0.227
+0.007 (+3.18%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de TRAW por análisis de gráficos similares
Alphio's TRAW stock price prediction model matches the current Traws Pharma Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.23 (+1.86%). The 1-week path is $0.24 (+3.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Traws Pharma Inc?
Traws Pharma Inc is not a good buy right now due to significant financial instability and negative market sentiment. The current price is $0.2271, which is down 82.92% year-to-date, indicating a severe decline in value. Additionally, the RSI is at 11.257, suggesting the stock is heavily oversold, but this could also indicate a lack of buying interest. The company has a forward P/E of 0, reflecting uncertainty about future earnings, and a gross margin of 0% in recent quarters, showing no profitability. The main risk is the delayed study for its lead flu drug, which has already caused a 28% drop in after-hours trading, highlighting the volatility and uncertainty surrounding the stock.
TRAW cerró en $0.23 el Friday, tras subir +3.18%
Traws Pharma Inc (TRAW) last closed at $0.2271, gaining +3.18%. These facts feed the 1-day and 1-week TRAW price prediction above.
Factores de la previsión
Los factores de la previsión de Traws Pharma Inc (TRAW) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de TRAW, ordenadas por similitud.
Análisis de estacionalidad de TRAW
Historically the probability of a positive November return for TRAW is 0.00%. March offers the highest probability of a positive month at 66.67%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de TRAW
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.18 | $1.37 | $1.48 | +505.02% |
| Dec 2026 | $0.90 | $1.15 | $1.17 | +405.28% |
En 2026, se proyecta que Traws Pharma Inc (TRAW) oscile entre $0.90 y $1.48.
Previsión mensual de Traws Pharma Inc para 2026
En Nov de 2026, se proyecta que Traws Pharma Inc promedie $1.37, con un mínimo de $1.18 y un máximo de $1.48.
En Dec de 2026, se proyecta que Traws Pharma Inc promedie $1.15, con un mínimo de $0.90 y un máximo de $1.17.
Artículos relacionados
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.